key: cord-0740543-uf16ec1n
authors: Roger, Guillaume; Pavot, Arthur; Bonnet, Isabelle; Ferlicot, Sophie; Mariette, Xavier
title: Phenotypic switch from non-active primary Sjögren's syndrome to severe systemic Lupus erythematosus after COVID-19 infection in an elderly man
date: 2021-05-26
journal: Joint Bone Spine
DOI: 10.1016/j.jbspin.2021.105228
sha: ed8021e8fc8a418a6e96038d381b194467350059
doc_id: 740543
cord_uid: uf16ec1n

nan

Auto-immune disorders have been reported following COVID-19, namely connective tissue disorders [1] . Features of systemic Lupus erythematosus (SLE) in the setting of COVID-19 infection were described [2 -4] , although an histopathological proof of SLE related organ damage in this setting is lacking. We report a case of SLE onset in an elderly man followed for quiescent primary Sjögren's syndrome, with evidence of immune complex glomerular disease.

A 76-year-old man, native from Cambodia, was admitted to the emergency department in SLE onset in elderly men, even with a history of Sjögren's syndrome, is very unusual. Higher serum levels of pro-inflammatory cytokines (TNF-α, IL-1 and IL-6) and decrease of regulatory T cells were found in patients with severe COVID-19. COVID-19 has been shown to trigger antiphospholipid antibodies which might play a pathogenic role in the thrombotic events frequently found in these patients [6] . Likewise, in our patient with a non-active autoimmune disease, the infection could result in the break of immune homeostasis, the onset of new pathogenic antibodies and in the switch of the phenotype and severity of the underlying auto-immune disease.

Consent : The patient's next of kin provided written informed consent for publication.

Contributors : GR, AP, IB, SF and XM managed the case, designed the work and drafted and revised the paper.

The authors declare that they have no competing interest.

Funding :. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. 

COVID-19 and the clinical course of rheumatic manifestations

Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology

Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient

The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection

European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

Presence of antiphospholipid antibodies in COVID-19: case series study

Data Availability Statement : The data underlying this article are available in the article